A GI-MAP reveals whether youre dealing with infections, candida, parasites, enzyme insufficiency, or inflammation information that determines which peptides to use, at what doses, and what other interventions need to happen simultaneously
Researchers sometimes pair it with BPC-157, another recovery peptide, to hypothesize possible synergistic repair effects in lab models
Beyond 500mcg, the risk-benefit ratio becomes less favorable
Owing to the insidious onset of symptoms and limitations in diagnostic testing, many patients experience delays in diagnosis, with studies indicating that 38% of patients wait five years or more before diagnosis[20]
Theres a great tax-treasure trove there, more than enough to solve NHS financial worries for years just slap them all with illegal importation of drugs without a licence fines
By modulating nitric oxide levels, BPC-157 creates conditions favorable for tissue repair while helping prevent excessive inflammation that can impair healing